Assistant Professor
My research efforts focus on developing new metabolomic approaches which can help us better understand adverse drug reactions and provide new therapeutic strategies. Currently, we are studying phase I and II metabolism of warfarin and applying this information to clinical applications by trying to understand the relationship between warfarin metabolism and anticoagulant therapy outcomes.